Marinomed Biotech AG

ACTIVE

Hovengasse 25, Korneuburg, Niederösterreich, Austriawww.marinomed.comPublic52 employeesEstablished: 2006-01-01

Clinical Trials

2 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2006

Overview

Trial Phase Distribution

Phase

Trials

Not Applicable

60.0%

Phase 1

20.0%

Phase 2

10.0%

Phase 3

10.0%

Trial Status Distribution

Active, not recruiting

20.0%

Completed

80.0%

Clinical Trials

Trials sponsored by this organization (10)

Lubricating Effectiveness of Carragelose Eye Drops in Patients Affected by Mild to Moderate Dry Eye

Not Applicable

Completed

interventional

Jan 202430 participants

Efficacy and Safety Evaluation of Inhaleen Inhalation in Hospitalized COVID-19 Patients

Not Applicable

Completed

interventional

Mar 202114 participants

Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care Workers

Not Applicable

Completed

interventional

Dec 2020300 participants

Demonstration of an Anti-allergic Effect in Subjects Treated With Callergin Nasal Spray in Comparison to Untreated Subjects and Subjects Treated With Vis Alpin® Alpensalz Nasal Spray, All Suffering From Grass Pollen Induced Rhinitis/Rhinoconjunctivitis

Not Applicable

Completed

interventional

Aug 202042 participants

Demonstration of a Decongestant Effect of "Coldamaris Akut" Compared to Saline Nasal Spray.

Not Applicable

Completed

interventional

Aug 202042 participants

Study to Investigate if Sucking a Coldamaris Lozenge Elutes Sufficient Iota-carrageenan to Inactivate Usual Common Cold Viruses

Not Applicable

Completed

interventional

Aug 202029 participants

Therapeutic Effect of Tacrosolv in Patients With Allergic Rhinoconjunctivitis

Phase 2

Completed

interventional

Aug 202064 participants

Clinical study to evaluate safety and efficacy of two different dosage groups of Tacrosolv eye drops in patients suffering from grass pollen-induced allergic rhinoconjunctivitis.

Phase 1

Active, not recruiting

Nov 2019107 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations